The present invention provides an improved technique for spinal fusion involving the administration of an HMG-CoA reductase inhibitor to a fusion. The HMG-CoA reductase inhibitor is preferably delivered to the site by a carrier. More preferably, the HMG-CoA reductase inhibitor is delivered to the site by a non-compressible delivery vehicle. The invention is suitable for promoting non-anatomic or heterotopic bone growth between any bony surfaces where bone growth is desired but does not naturally occur.

 
Web www.patentalert.com

< Modified silane compounds

< Cushioning devices, gelatinous elastomer materials, and devices made therefrom

> Hemostatic compositions and devices

> Air duct seal for HVAC case

~ 00287